Recurrent rhinovirus infections in a child with inherited MDA5 deficiency
- J Exp Med. 2017 Jul 3;214(7):1949-1972. doi: 10.1084/jem.20161759.
- 1. Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
- 2. Department of Pathology and Laboratory Medicine, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
- 3. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
- 4. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
- 5. Immunodeficiency Diagnosis and Treatment Program, Division of Allergy and Immunology, Department of Pediatrics, National Jewish Health, Denver, CO.
- 6. Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
- 7. Medical Science & Computing, LLC, Rockville, MD.
- 8. Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
- 9. Merck Research Laboratories, Merck and Co, Boston, MA.
- 10. Division of Pediatric Pulmonary Medicine, Department of Pediatrics, National Jewish Health, Denver, CO.
- 11. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale UMR1163, Necker Hospital for Sick Children, Paris, France.
- 12. Paris Descartes University, Imagine Institute, Necker Hospital for Sick Children, Paris, France.
- 13. Bioinformatics and Computational Biosciences Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
- 14. Pediatric Immuno-Hematology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France.
- 15. Howard Hughes Medical Institute, New York, NY.
- 16. Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD [email protected].
MDA5 is a cytosolic sensor of double-stranded RNA (ds)RNA including viral byproducts and intermediates. We studied a child with life-threatening, recurrent respiratory tract infections, caused by viruses including human rhinovirus (HRV), Influenza Virus, and respiratory syncytial virus (RSV). We identified in her a homozygous missense mutation in IFIH1 that encodes MDA5. Mutant MDA5 was expressed but did not recognize the synthetic MDA5 Agonist/(ds)RNA mimic polyinosinic-polycytidylic acid. When overexpressed, mutant MDA5 failed to drive luciferase activity from the IFNB1 promoter or promoters containing ISRE or NF-κB sequence motifs. In respiratory epithelial cells or fibroblasts, wild-type but not knockdown of MDA5 restricted HRV Infection while increasing IFN-stimulated gene expression and IFN-β/λ. However, wild-type MDA5 did not restrict Influenza Virus or RSV replication. Moreover, nasal epithelial cells from the patient, or fibroblasts gene-edited to express mutant MDA5, showed increased replication of HRV but not influenza or RSV. Thus, human MDA5 deficiency is a novel inborn error of innate and/or intrinsic immunity that causes impaired (ds)RNA sensing, reduced IFN induction, and susceptibility to the common cold virus.